Taysha Gene Therapies
TSHA
$2.57
Share price
-0.39%
Change (1 day)
261.97%
Change (1 year)
Taysha Gene Therapies (TSHA) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $97.79 M
According to Taysha Gene Therapies's latest financial reports the company's total liabilities are $97.79 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Taysha Gene Therapies - Total liabilities on balance sheet (from 2020 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $0.12 B | 5.7% |
| 2021-12-31 | $0.11 B | 1464.49% |
| 2020-12-31 | $7.57 M | 4952.67% |
| 2019-12-31 | $0.15 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $27.91 M | -71.45% | 🇺🇸 USA |